Mosunetuzumab-Axgb 1 mg/mL Suppliers & Bulk Manufacturers
Available Forms: Injection
Available Strengths: 1 mg/mL
Reference Brands: Lunsumio (USA/EU)
Category: Oncology Cancer Care
Mosunetuzumab-axgb is a bispecific CD20-directed CD3 T-cell engager. It binds CD20 on B-cells and CD3 on T-cells, bringing T-cells into proximity with cancerous B-cells so the immune system can attack and destroy them. It is used to treat adult patients with relapsed or refractory Follicular Lymphoma (a type of non-Hodgkin B-cell lymphoma) after they have had at least two prior systemic therapies.
Mosunetuzumab-Axgb — third party manufacturing & bulk supply
Mosunetuzumab-Axgb 1 mg/mL is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:
What to include when you enquire
- Destination market — determines which manufacturers hold the right site-level approvals
- First order quantity and estimated annual volume
- Whether you need a registration dossier or the product is already registered
- Packaging, labelling and language requirements
- Incoterms and required shelf life
Manufacturers of Mosunetuzumab-Axgb listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding. Narcotic drugs and controlled substances are supplied strictly against valid import and export permits issued by the competent authorities.
Request a quote for Mosunetuzumab-Axgb →The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Frequently Asked Questions
Mosunetuzumab-axgb is used to treat relapsed or refractory follicular lymphoma in adults who have received at least two prior systemic therapies.
Mosunetuzumab-axgb is a bispecific monoclonal antibody designed to bind both CD20 on B-cells and CD3 on T-cells, directing the immune system to destroy malignant B-cells.
The trade name is Lunsumio.
Lunsumio is manufactured by Genentech, a member of the Roche Group.
The generic name is mosunetuzumab-axgb.
The brand name is Lunsumio.
It is manufactured in the United States and Europe by Genentech/Roche.
Related Products
Fruquin 5 Mg (Fruquintinib)
Strength:
5 Mg
Form: Capsules
Reference Brands: Everest Bangladesh altd.
View Details
Vorinostat
Strength:
100 mg
Form: Capsules
Reference Brands: Zolinza (USA/EU), Vornat (India)
View Details
Panobinostat Lactate
Strength:
10 mg, 15 mg, 20 mg
Form: Capsules
Reference Brands: Farydak (USA/EU),
View Details
Gilteritinib
Strength:
40 mg
Form: Tablets
Reference Brands: Xospata (USA/India), LuciGil (Asia)
View DetailsQuick Response Guaranteed | Verified Suppliers
